- Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failureWeerawat, Manosuthi; Supeda, Thongyen; Samruay, Nilkamhang; Sukanya, Manosuthi; Somnuek, SungkanuparphAIDS Research and Therapy, 2012, 9(1): 8.被引 4
- A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responsesKenneth A Lichtenstein; Carl Armon; Vijaya Nagabhushanam; Benjamin J Efaw; Ashley Frazer-Abel; Melissa E Hiserote; Rafeul AlamAntiviral Therapy, 2012, 17(7): 1301-1309.
- Advances in Long-Acting Agents for the Treatment of HIV InfectionAadia I., Rana; Jose R., Castillo-Mancilla; Karen T., Tashima; Raphael L., LandovitzDrugs, 2020, 80(6): 535-545.被引 4
期刊论文
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy
13被引5阅读
